Diversities of Mechanism in Patients with VHL Syndrome and diabetes: A Report of Two Cases and Literature Review
Yanlei Wang,Zhaoxiang Liu,Wenhui Zhao,Chenxiang Cao,Luqi Xiao,Jianzhong Xiao
DOI: https://doi.org/10.2147/dmso.s443495
2024-04-09
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yanlei Wang, &ast Zhaoxiang Liu, &ast Wenhui Zhao, Chenxiang Cao, Luqi Xiao, Jianzhong Xiao Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, 102218, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianzhong Xiao, Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102218, People's Republic of China, Tel/Fax +8610-5611-9057, Email Background: Von Hippel-Lindau (VHL) syndrome is characterized by tumorous lesions affecting multiple organs. Pancreatic involvement in VHL syndrome can present as endocrine tumors and pancreatic cysts, which can interfere with both exocrine and endocrine functions of the pancreas. Diabetes is an uncommon complication of VHL syndrome. Purpose: This study aims to summarize the various mechanisms of diabetes in VHL syndrome by reporting two cases and conducting a literature review. Methods: We analyzed the clinical and imaging data of two patients with VHL syndrome and diabetes. Additionally, we reviewed the existing literature to explore the clinical diversities and management strategies for VHL syndrome complicated with diabetes. Results: The first patient presented with liver metastasis of pancreatic neuroendocrine tumor and multiple pheochromocytoma. After surgery, the patient's diabetic control improved, as evidenced by a significant reduction in insulin dosage. This indicates a potential insulin resistance due to elevated metanephrine levels prior to surgery and partial insulin deficiency caused by distal pancreatectomy. The second patient had multiple hemangioblastomas, as well as multiple pancreatic cysts and positive pancreatic islet autoantibodies. Diabetes in this case may be attributed to pancreatic lesions and the coexistence of autoimmune insulitis. A literature review of other patients with VHL combined with diabetes revealed multiple mechanisms, including increased catecholamine levels, pancreatic lesions, surgical removal of pancreatic tissue, endocrine treatment, and possibly the coexistence of autoimmune insulitis. Conclusion: VHL syndrome complicated with diabetes involves diverse mechanisms. Keywords: von Hippel-Lindau syndrome, diabetes, pancreatic neuroendocrine tumor Von Hippel-Lindau (VHL) syndrome is an autosomal dominant inherited disease with a prevalence of 1 in 36,000 live births and an average onset age of 26 years. It is caused by mutations in the VHL gene on the short arm of chromosome 3, leading to the inactivation of VHL protein. The normal VHL protein works to degrade hypoxia-inducible factors (HIFs). When VHL protein is inactivated, the inhibition of HIFs is weakened, causing hypoxic responses in the body. This affects glucose uptake, metabolism, angiogenesis, extracellular matrix generation, cell proliferation and directly promotes tumor formation. 1,2 VHL syndrome is characterized by tumorous lesions affecting multiple organs, such as central nervous system and retinal hemangioblastomas (60–84%), pheochromocytoma (10–20%), renal cysts and renal cancer (25–60%), pancreatic neuroendocrine tumors (12–17%), etc. 3 Depending on the severity of HIF accumulation, VHL syndrome can manifest as type 1 (low risk for pheochromocytoma), type 2A (high risk for pheochromocytoma and low risk for renal cell carcinoma), type 2B (high risk for pheochromocytoma and renal cell carcinoma), and type 2C (high risk for pheochromocytoma only). 4 Pancreatic involvement in VHL syndrome can present as endocrine tumors and pancreatic cysts, along with other abnormalities in the pancreas. These lesions can interfere with both exocrine and endocrine functions of the pancreas. This article focuses on the features of VHL syndrome in combination with diabetes through the analysis of two case studies. We will examine existing data regarding VHL syndrome and its lesser-known correlation with significant glycemic abnormalities in the preoperative, perioperative, and postoperative stages. Additionally, we will discuss the clinical management of these cases. On August 5, 2020, a 28-year-old female patient was admitted to our hospital with liver metastasis of pancreatic neuroendocrine tumor and combined with bladder and adrenal pheochromocytoma. In 2017, at the age of 25, the patient underwent transurethral resection of a bladder tumor after a routine physical examination revealing a mass in the bladder. At that time, her blood pressure and glucose levels were within normal range, and the pathology confirmed pheochromocytoma. During a follow-up examination in 2018, a so -Abstract Truncated-
endocrinology & metabolism